Russell Investments Group Ltd. Buys 8,557 Shares of Agilent Technologies, Inc. (NYSE:A)

Russell Investments Group Ltd. increased its stake in shares of Agilent Technologies, Inc. (NYSE:AGet Rating) by 2.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 360,532 shares of the medical research company’s stock after purchasing an additional 8,557 shares during the quarter. Russell Investments Group Ltd. owned about 0.12% of Agilent Technologies worth $43,865,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. Vanguard Group Inc. lifted its holdings in Agilent Technologies by 1.1% in the first quarter. Vanguard Group Inc. now owns 24,531,170 shares of the medical research company’s stock valued at $3,246,209,000 after buying an additional 261,435 shares during the period. Price T Rowe Associates Inc. MD lifted its holdings in Agilent Technologies by 1.4% in the second quarter. Price T Rowe Associates Inc. MD now owns 16,652,764 shares of the medical research company’s stock valued at $1,977,848,000 after buying an additional 223,279 shares during the period. Massachusetts Financial Services Co. MA lifted its holdings in Agilent Technologies by 42.2% in the second quarter. Massachusetts Financial Services Co. MA now owns 5,851,153 shares of the medical research company’s stock valued at $694,942,000 after buying an additional 1,736,168 shares during the period. Pictet Asset Management SA lifted its holdings in Agilent Technologies by 4.1% in the second quarter. Pictet Asset Management SA now owns 5,476,317 shares of the medical research company’s stock valued at $650,476,000 after buying an additional 214,860 shares during the period. Finally, FMR LLC lifted its holdings in Agilent Technologies by 12.7% in the second quarter. FMR LLC now owns 3,415,490 shares of the medical research company’s stock valued at $405,657,000 after buying an additional 384,519 shares during the period.

Agilent Technologies Trading Down 2.1 %

Shares of NYSE:A opened at $155.69 on Wednesday. Agilent Technologies, Inc. has a 12 month low of $112.52 and a 12 month high of $160.26. The company has a quick ratio of 1.47, a current ratio of 2.03 and a debt-to-equity ratio of 0.52. The company’s fifty day simple moving average is $152.37 and its 200 day simple moving average is $138.42. The firm has a market cap of $46.10 billion, a price-to-earnings ratio of 37.34, a PEG ratio of 2.76 and a beta of 1.07.

Agilent Technologies (NYSE:AGet Rating) last released its earnings results on Monday, November 21st. The medical research company reported $1.53 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.14. The business had revenue of $1.85 billion during the quarter, compared to the consensus estimate of $1.76 billion. Agilent Technologies had a net margin of 18.31% and a return on equity of 30.28%. The firm’s revenue for the quarter was up 11.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.21 earnings per share. As a group, research analysts forecast that Agilent Technologies, Inc. will post 5.64 EPS for the current fiscal year.

Agilent Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 25th. Investors of record on Tuesday, January 3rd will be given a $0.225 dividend. The ex-dividend date is Friday, December 30th. This represents a $0.90 dividend on an annualized basis and a yield of 0.58%. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.21. Agilent Technologies’s dividend payout ratio (DPR) is 21.58%.

Agilent Technologies announced that its board has initiated a share repurchase program on Monday, January 9th that authorizes the company to buyback $2.00 billion in shares. This buyback authorization authorizes the medical research company to reacquire up to 4.4% of its stock through open market purchases. Stock buyback programs are often an indication that the company’s board believes its stock is undervalued.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the stock. UBS Group increased their target price on shares of Agilent Technologies from $152.00 to $170.00 and gave the stock a “buy” rating in a report on Tuesday, December 20th. SVB Leerink increased their target price on shares of Agilent Technologies from $160.00 to $170.00 and gave the stock an “outperform” rating in a report on Friday, January 6th. StockNews.com assumed coverage on shares of Agilent Technologies in a report on Wednesday, October 12th. They issued a “strong-buy” rating on the stock. Citigroup increased their target price on shares of Agilent Technologies from $145.00 to $150.00 and gave the stock a “neutral” rating in a report on Tuesday, November 22nd. Finally, Robert W. Baird increased their target price on shares of Agilent Technologies from $160.00 to $170.00 in a report on Tuesday, November 22nd. Three investment analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $161.36.

Insider Activity at Agilent Technologies

In related news, VP Padraig Mcdonnell sold 672 shares of the firm’s stock in a transaction on Tuesday, December 13th. The shares were sold at an average price of $160.00, for a total value of $107,520.00. Following the completion of the transaction, the vice president now owns 15,529 shares of the company’s stock, valued at $2,484,640. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, VP Jacob Thaysen sold 9,700 shares of Agilent Technologies stock in a transaction dated Wednesday, November 30th. The shares were sold at an average price of $154.63, for a total value of $1,499,911.00. Following the completion of the transaction, the vice president now owns 87,699 shares of the company’s stock, valued at approximately $13,560,896.37. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, VP Padraig Mcdonnell sold 672 shares of Agilent Technologies stock in a transaction dated Tuesday, December 13th. The shares were sold at an average price of $160.00, for a total transaction of $107,520.00. Following the completion of the transaction, the vice president now directly owns 15,529 shares of the company’s stock, valued at approximately $2,484,640. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 209,039 shares of company stock valued at $32,268,881.

Agilent Technologies Company Profile

(Get Rating)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

Featured Stories

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.